Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Dupilumab for skin problems might reactivate hair loss in some patients.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Grape seed extract is good for skin care, with antioxidant, anti-inflammatory, and anti-cancer effects.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Probiotic bacteria improved skin and hair health in aged mice.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

New acne treatments show promise as alternatives to traditional therapies.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Vitamin D boosts a specific protein in skin cells linked to hair follicles.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

IL-36α helps grow new hair follicles and speeds up wound healing.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Antibody treatments show promise for hair loss but need more research.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.